Technical Analysis for HOLX - Hologic, Inc.

Grade Last Price % Change Price Change
grade B 46.85 -1.82% -0.87
HOLX closed down 1.82 percent on Friday, March 22, 2019, on 45 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical HOLX trend table...

Date Alert Name Type % Chg
Mar 22 Fell Below 20 DMA Bearish 0.00%
Mar 22 Bollinger Band Squeeze Range Contraction 0.00%
Mar 21 Bollinger Band Squeeze Range Contraction -1.82%
Mar 20 20 DMA Support Bullish -0.95%
Mar 20 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.95%
Mar 20 Bollinger Band Squeeze Range Contraction -0.95%
Mar 20 Outside Day Range Expansion -0.95%
Mar 19 20 DMA Support Bullish -1.22%
Mar 19 Bollinger Band Squeeze Range Contraction -1.22%
Mar 19 Inside Day Range Contraction -1.22%

Older signals for HOLX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Hologic, Inc. develops, manufactures, and supplies diagnostics, medical imaging systems, and surgical products for women. The company's Breast Health segment offers full field digital mammography, C-View, screen-film mammography, computer aided detection, Trident specimen radiography, and stereotactic breast biopsy systems; healthcome mammography, breast biopsy, and breast brachytherapy products; and breast tomosynthesis, Selenia full field digital mammography platform, SecurView workstation, MammoPad breast cushions, photoconductor coatings, and Sentinelle medical MRI breast coils and workstations. Its Diagnostics segment provides APTIMA family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays, instrumentation, Invader chemistry platform, Cervista HPV tests, and ThinPrep system. The company's GYN Surgical segment offers NovaSure system to treat women with excessive menstrual bleeding; MyoSure system for the hysteroscopic removal of fibroids; Towerfree Hysteroscopy System for the visualization and inspection of the uterine cavity; Aquilex Fluid Control System to measure the inflow and outflow of fluid from the patient during hysteroscopic procedures; and Adiana system, a procedure for permanent female contraception. Its Skeletal Health segment provides QDR X-Ray bone densitometers that assess the bone density of fracture sites; Sahara clinical bone sonometers, which assess the bone density of heels; and Mini C-Arm imaging systems to perform minimally invasive surgical procedures on a patient's extremities. The company sells its products through direct sales and service forces, a network of independent distributors, and sales representatives primarily in the United States, Europe, and the Asia-Pacific. The company has a strategic alliance with Quest Diagnostics Incorporated. Hologic, Inc. was founded in 1985 and is headquartered in Bedford, Massachusetts.
Medicine Medical Specialties Clinical Medicine Imaging Breast Cancer X Ray MRI Surgical Products Breast Surgery Cancer Screening HPV Hybridization Mammography Breast Imaging Diagnostics Medical Imaging Systems
Is HOLX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 48.11
52 Week Low 35.1
Average Volume 1,931,905
200-Day Moving Average 41.7667
50-Day Moving Average 45.4888
20-Day Moving Average 47.174
10-Day Moving Average 47.302
Average True Range 0.7813
ADX 20.99
+DI 24.3827
-DI 20.8601
Chandelier Exit (Long, 3 ATRs ) 45.7661
Chandelier Exit (Short, 3 ATRs ) 48.2539
Upper Bollinger Band 47.9377
Lower Bollinger Band 46.4103
Percent B (%b) 0.29
BandWidth 3.2378
MACD Line 0.5461
MACD Signal Line 0.6843
MACD Histogram -0.1382
Fundamentals Value
Market Cap 13.13 Billion
Num Shares 280 Million
EPS 2.68
Price-to-Earnings (P/E) Ratio 17.48
Price-to-Sales 3.49
Price-to-Book 3.63
PEG Ratio 2.06
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 48.25
Resistance 3 (R3) 48.39 48.07 48.01
Resistance 2 (R2) 48.07 47.71 48.00 47.93
Resistance 1 (R1) 47.46 47.50 47.30 47.32 47.86
Pivot Point 47.14 47.14 47.06 47.07 47.14
Support 1 (S1) 46.53 46.78 46.37 46.39 45.84
Support 2 (S2) 46.21 46.57 46.14 45.77
Support 3 (S3) 45.60 46.21 45.69
Support 4 (S4) 45.46